Evaluation of QDOT MICRO™ Catheter for Pulmonary Vein Isolation in Subjects With Paroxysmal Atrial Fibrillation
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Andrea Natale
Texas Cardiac Arrhythmia Research Foundation
Principal Investigator - Ashish Patel
Wakemed Heart and Vascular
Principal Investigator - Ayman Hussein
The Cleveland Clinic
Principal Investigator - Chris Ellis
VUMC
Principal Investigator - Craig Delaughter
Texas Heart Health and Vascular
Principal Investigator - Daniel Melby
Abbott Northwestern
Principal Investigator - Emerson Liu
Allegheny College
Principal Investigator - Francis Marchlinksi
University of Pennsylvania Health System
Principal Investigator - Gery Tomassoni
Baptist Hospital
Principal Investigator - Jose Osorio
Grandview Medical Center
Principal Investigator - Luigi DiBiase
Montefiore
Principal Investigator - Michael Cutler
Intermountain Health Care, Inc.
Principal Investigator - Miguel Valderabanno
The Methodist Hospital Research Institute
Principal Investigator - Robert Fishel
JFK Hospital
Principal Investigator - Saumil Oza
Ascension St. Vincent's
Principal Investigator - Tristram Bahnson
Duke University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
22 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Grandview Medical Center
Birmingham, Alabama, United States
- University of Alabama
Birmingham, Alabama, United States
- Jfk Medical Center
Atlantis, Florida, United States
- Ascension St. Vincent'S
Jacksonville, Florida, United States
- Florida Hospital
Orlando, Florida, United States
- Baptist Health
Lexington, Kentucky, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- Abbott Northwestern Hospital Clinic
Minneapolis, Minnesota, United States
- Mt. Sinai School of Medicine
New York, New York, United States
- Nyu Langone
New York, New York, United States
- New York Presbyterian Hospital
New York, New York, United States
- Montefiore Medical Center - Albert Einstein
The Bronx, New York, United States
- Duke University Medical Center
Durham, North Carolina, United States
- Wakemed Heart & Vascular
Raleigh, North Carolina, United States
- Cleveland Clinic
Cleveland, Ohio, United States
- Ohio State University
Columbus, Ohio, United States
- University of Penn Health System
Philadelphia, Pennsylvania, United States
- Texas Heart Health and Vascular
Arlington, Texas, United States
- St. David'S - Tcar
Austin, Texas, United States
- Houston Methodist Hospital
Houston, Texas, United States
- Intermountain Medical Center
Murray, Utah, United States
- Virginia Commonwealth University
Richmond, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jan 2019
- Primary completion
- 17 Feb 2022
- Completion
- 17 Feb 2022
- Last update posted
- 16 Mar 2023
- Registered enrollment
- 283
- Registry id
- NCT03775512
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.